Patients were censored if they met any of the following criteria: (1) discontinuing hydroxyzine or haloperidol while CAM or CAM-ICU is still positive, (2) discharge from the hospital, (3) death, and (4) switching to another drug for treating delirium from intravenous hydroxyzine or haloperidol (in cases with drug switching, we also extracted whether the switching from intravenous to oral drugs was due to the resumption of eating and drinking)
Conclusiones de los autores: Los medicamentos tipo GLP-1 son muy efectivos y han cambiado la vida de muchas personas con obesidad y diabetes
Experts Consensus Group on the Body Quality Management Approach and Process for Overweight/Obese Infertility Patients
Gross Medicare Spending on Ozempic and Other GLP-1s Is Already Skyrocketing Even Though Medicare Cannot Cover The Drugs for Weight Loss A KFF analysis shows that gross total Medicare spending on Ozempic and other similar drugs has increased dramatically in recent years even though Medicare is explicitly prohibited by law from covering the drugs for obesity
N Engl J Med 2019;381:63746
Looking Forward: The Future of Anti-Inflammatory Medicine The anti-inflammatory properties of GLP-1 receptor agonists represent an exciting frontier in medicine